These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19958354)

  • 1. Evidence of a colocalisation of osteoprotegerin (OPG) with von Willebrand factor (VWF) in platelets and megakaryocytes alpha granules. Studies from normal and grey platelets.
    Chollet ME; Brouland JP; Bal dit Sollier C; Bauduer F; Drouet L; Bellucci S
    Br J Haematol; 2010 Mar; 148(5):805-7. PubMed ID: 19958354
    [No Abstract]   [Full Text] [Related]  

  • 2. Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes.
    Cramer EM; Vainchenker W; Vinci G; Guichard J; Breton-Gorius J
    Blood; 1985 Dec; 66(6):1309-16. PubMed ID: 3877532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray platelet syndrome. Dissociation between abnormal sorting in megakaryocyte alpha-granules and normal sorting in Weibel-Palade bodies of endothelial cells.
    Gebrane-Younès J; Cramer EM; Orcel L; Caen JP
    J Clin Invest; 1993 Dec; 92(6):3023-8. PubMed ID: 7504696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weibel-Palade bodies in pig megakaryocytes.
    Gebrane-Younes J; Drouet L; Caen JP; Orcel L
    Biol Struct Morphog; 1988; 1(2):58-62. PubMed ID: 3261604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mepacrine labelling test and uranaffin cytochemical reaction in human megakaryocytes.
    Hourdillé P; Fialon P; Belloc F; Boisseau MR; Andrieu JM
    Thromb Haemost; 1982 Jun; 47(3):232-5. PubMed ID: 7112496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some immunofluorescent observations on factor VIII/von Willebrand factor in dogs.
    Potter EV; Shaughnessy MA; Green D
    Thromb Haemost; 1980 Oct; 44(2):56-61. PubMed ID: 6779399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative disorders of platelets and megakaryocytes.
    Nurden AT
    J Thromb Haemost; 2005 Aug; 3(8):1773-82. PubMed ID: 16102044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncoordinated expression of fibrinogen compared with thrombospondin and von Willebrand factor in maturing human megakaryocytes.
    Cramer EM; Debili N; Martin JF; Gladwin AM; Breton-Gorius J; Harrison P; Savidge GF; Vainchenker W
    Blood; 1989 Apr; 73(5):1123-9. PubMed ID: 2649167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins.
    Villeneuve J; Block A; Le Bousse-Kerdilès MC; Lepreux S; Nurden P; Ripoche J; Nurden AT
    Exp Hematol; 2009 Jul; 37(7):849-56. PubMed ID: 19410025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of a circulating protein into alpha granules of megakaryocytes.
    Handagama PJ; Bainton DF
    Blood Cells; 1989; 15(1):59-72. PubMed ID: 2930854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor is the most reliable immunohistochemical marker for megakaryocytes of myelodysplastic syndrome and chronic myeloproliferative disorders.
    Chuang SS; Jung YC; Li CY
    Am J Clin Pathol; 2000 Apr; 113(4):506-11. PubMed ID: 10761451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryocytes from the marrow of a patient with Glanzmann's thrombasthenia lacked GP IIb-IIIa complexes.
    Hourdillé P; Fialon P; Belloc F; Namur M; Boisseau MR; Nurden AT
    Thromb Haemost; 1986 Aug; 56(1):66-70. PubMed ID: 3535160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-selectin mRNA is expressed at a later phase of megakaryocyte maturation than mRNAs for von Willebrand factor and glycoprotein Ib-alpha.
    Schick PK; Konkle BA; He X; Thornton RD
    J Lab Clin Med; 1993 May; 121(5):714-21. PubMed ID: 7683032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
    Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
    Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet density-dependent partition of platelet-von Willebrand factor between alpha granule and non-alpha granule pools.
    Parker RI; Shafer BC; Gralnick HR
    Thromb Haemost; 1987 Oct; 58(3):911-4. PubMed ID: 3501617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitation of platelet-bound von Willebrand factor in normal subjects and patients with coronary heart disease].
    Li N; Li J
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Aug; 19(4):240-2, 268-9. PubMed ID: 1813292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of alpha granules to the membrane systems of platelets and megakaryocytes.
    Zucker-Franklin D
    Blood Cells; 1989; 15(1):73-9. PubMed ID: 2930855
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.
    Bowie EJ; Solberg LA; Fass DN; Johnson CM; Knutson GJ; Stewart ML; Zoecklein LJ
    J Clin Invest; 1986 Jul; 78(1):26-30. PubMed ID: 3088043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma.
    Vinholt PJ; Overgaard M; Diederichsen AC; Mickley H; Poulsen TS; Sand NP; Nybo M; Rasmussen LM
    Thromb Res; 2013 May; 131(5):396-400. PubMed ID: 23531238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
    Pfueller SL; Howard MA; White JG; Menon C; Berry EW
    Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.